BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

BG9924

Subcutaneous administration of BG9924 given every other week for 12 weeks

OTHER

Placebo Comparator

Subcutaneous administration of placebo given every other week for 12 weeks

Trial Locations (1)

93404

Stanford University, Palo Alto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY

NCT00458861 - BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter